title: The clinical relevance of endocrine-therapy-induced changes in lipid metabolism in breast cancer patients.
authors.affiliation: Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Frassoldati
authors.forename: Valentina
authors.initials: V
authors.lastname: Guarneri
authors.forename: PierFranco
authors.initials: P
authors.lastname: Conte
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy*; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology* / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000494:pharmacology; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D004967:Estrogens; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D007249:Inflammation; D050356:Lipid Metabolism / Q000187:drug effects*; D008099:Liver / Q000187:drug effects; D008593:Menopause; D009376:Neoplasms, Hormone-Dependent / Q000097:blood / Q000188:drug therapy*; D011374:Progesterone; D011960:Receptors, Estrogen / Q000187:drug effects / Q000502:physiology; D011980:Receptors, Progesterone / Q000187:drug effects / Q000502:physiology; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology
chemical_list: D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D004965:Estrogen Antagonists; D004967:Estrogens; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D020845:Selective Estrogen Receptor Modulators; D000077267:Fulvestrant; D011374:Progesterone; D004958:Estradiol; D002784:Cholesterol